Introduction: What is Durvalumab?
Durvalumab is a monoclonal antibody that belongs to a class of medications known as immune checkpoint inhibitors. It is primarily used in the treatment of certain types of cancer, including non-small cell lung cancer (NSCLC) and urothelial carcinoma. By targeting the programmed death-ligand 1 (PD-L1), Durvalumab helps to enhance the body?s immune response against cancer cells, allowing the immune system to recognize and attack tumors more effectively.
Uses of Durvalumab
Durvalumab is approved for several medical uses, including:
Best Hospital Near me Chennai